...
首页> 外文期刊>Bioorganic and medicinal chemistry >Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.
【24h】

Novel anti-HIV cyclotriazadisulfonamide derivatives as modeled by ligand- and receptor-based approaches.

机译:通过基于配体和受体的方法建模的新型抗HIV环三氮二磺酰胺衍生物。

获取原文
获取原文并翻译 | 示例

摘要

Computer-aided prediction of new anti-HIV compounds, derived from substructures of 2-amino-6-arylsulfonylbenzonitriles and cyclotriazadisulfonamide analogues, has been reported. A ligand-based approach, namely MIA-QSAR, and a docking evaluation were used to model the title compounds, macrocycles containing a trisubstituted benzene moiety. According to the MIA-QSAR method, predicted potencies for proposed compounds were up to seven times higher than that of the experimentally most active compound of training set. Moreover, we have used docking approaches to study the binding orientations and predict binding affinities of these compounds in CD4 receptor.
机译:据报道,计算机辅助预测了新的抗HIV化合物,该化合物衍生自2-氨基-6-芳基磺酰基苄腈的亚结构和环三氮二磺酰胺类似物。使用基于配体的方法(即MIA-QSAR)和对接评估来建模标题化合物,即含有三取代苯部分的大环。根据MIA-QSAR方法,拟议化合物的预测效价比实验组中实验活性最高的化合物的预测效价高7倍。此外,我们已经使用对接方法来研究这些化合物在CD4受体中的结合方向并预测其结合亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号